Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
TETRAPHASE PHARMACEUTICALS INC (TTPH)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Jul-07-13 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 105.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -5.0% |
| Selling, general and administrative | 664.9% | 196.1% | 244.9% | | | | | |
| Research and development | 308.9% | 290.3% | 1052.2% | 1239.3% | 631.3% | 680.7% | 300.5% | |
| General and administrative | | | | 373.4% | 179.0% | 142.1% | 68.4% | 19.6% |
| EBITDA | -907.0% | -384.6% | -1192.7% | -1507.2% | -708.6% | -721.5% | -267.6% | -88.3% |
| Depreciation | 8.6% | 3.0% | 4.5% | 5.5% | 1.7% | 1.4% | 1.2% | 2.0% |
| EBIT | -915.6% | -387.6% | -1197.1% | -1512.7% | -710.2% | -722.9% | -268.8% | -90.3% |
| Pre-tax income | -950.2% | -381.7% | -1187.2% | -1505.9% | -711.9% | -733.6% | -0.3% | -95.9% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 282.3% | 0.0% |
| Net income | -950.2% | -381.7% | -1187.2% | -1505.9% | -711.9% | -733.6% | -282.6% | -95.9% |
|